ELUT - Elutia Inc - Ordinary Shares - Class A
IEX Last Trade
4.09
-0.010 -0.244%
Share volume: 42,205
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.10
-0.01
-0.24%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-15 | 2022-11-14 | 2023-03-23 | 2023-05-12 | 2023-08-14 | 2023-11-14 | 2024-03-11 | 2024-05-13 | |
Total revenue | 12.638 M | 12.389 M | 12.665 M | 13.050 M | 10.296 M | 6.127 M | -4.728 M | 6.694 M | |
Cost of revenue | 7.740 M | 7.340 M | 7.671 M | 6.719 M | 9.316 M | 3.286 M | -5.629 M | 3.851 M | |
Gross profit | 4.898 M | 5.049 M | 4.994 M | 6.331 M | 980.000 K | 2.841 M | 901.000 K | 2.843 M | |
3.08% | -1.09% | 26.77% | -84.52% | 189.90% | -68.29% | 215.54% | |||
Operating expenses | 13.080 M | 11.368 M | 10.111 M | 10.838 M | 8.794 M | 6.116 M | 5.842 M | 9.537 M | |
Selling general and admin | 10.463 M | 9.402 M | 8.026 M | 9.035 M | 7.623 M | 5.559 M | 4.974 M | 8.365 M | |
Research and development | 2.617 M | 1.966 M | 2.085 M | 1.803 M | 1.171 M | 557.000 K | 868.000 K | 1.172 M | |
Total expenses | 20.820 M | 18.708 M | 17.782 M | 17.557 M | 18.110 M | 9.402 M | 213.000 K | 13.388 M | |
-10.14% | -4.95% | -1.27% | 3.15% | -48.08% | -97.73% | 6,185.45% | |||
Operating income | -8.182 M | -6.319 M | -5.117 M | -4.507 M | -7.814 M | -3.275 M | -4.941 M | -6.694 M | |
Ebit | -8.182 M | -6.319 M | -5.117 M | -4.507 M | -7.814 M | -3.275 M | -4.941 M | -6.694 M | |
Pretax income | -9.386 M | -9.898 M | -5.442 M | -7.962 M | -10.609 M | -8.507 M | -14.143 M | -17.986 M | |
5.45% | -45.02% | 46.31% | 33.25% | -19.81% | 66.25% | 27.17% | |||
Income tax | 12.000 K | 12.000 K | -2.000 K | 12.000 K | 12.000 K | 12.000 K | -8.000 K | 8.000 K | |
Net income basic | -9.398 M | -9.910 M | -5.440 M | -7.974 M | -10.621 M | -9.747 M | -9.314 M | -17.994 M | |
-5.45% | 45.11% | -46.58% | -33.20% | 8.23% | 4.44% | -93.19% | |||
Net income | -9.398 M | -9.910 M | -5.440 M | -7.974 M | -10.621 M | -9.747 M | -9.314 M | -17.994 M | |
-5.45% | 45.11% | -46.58% | -33.20% | 8.23% | 4.44% | -93.19% |